Science & Technology
A 13-Week Oral Gavage Toxicity Study of OLX-07010 in Beagle Dogs Followed by a 4-Week Recovery Period
Department of Health and Human Services — National Institutes of Health
Opportunity #: 1R44AG091987-01
Award Ceiling
$500K
Award Floor
$500K
Close Date
Aug 19, 2026
157 days leftTotal Funding
$500K
Expected Awards
1
Posted Date
Aug 20, 2025
Cost Sharing Required
No
Grants.gov ID
sbir-1R44AG091987-01
Description
SBIR Phase Phase I award: "A 13-Week Oral Gavage Toxicity Study of OLX-07010 in Beagle Dogs Followed by a 4-Week Recovery Period" awarded to OLIGOMERIX INC in WHITE PLAINS, New York. Funded by Department of Health and Human Services (National Institutes of Health). Award amount: $499,879. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.
Eligible Applicants
Small businesses
Apply on Grants.gov
Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.
View on Grants.govDisclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.